Saving lives by lowering the cost of drug development
How protein science can help fight diseases such as Alzheimer's
Low-cost, portable tests to diagnose deadly diseases
Our latest investment news and updates
BGF leads a multi-million pound investment in Arborea
Arborea – which is industrialising photosynthesis to expand the world’s food supply – has completed a funding round led by…
BGF announces £100m milestone in life sciences investment
BGF has broken the £100 million investment milestone, backing more than 30 businesses across the fields of diagnostics, medtech and…
BGF leads £7m investment round into Phico Therapeutics
Cambridge based biotechnology company, Phico Therapeutics (‘Phico’), announced today it has received £7 million in funding from a consortium of…
Our latest thinking on investing and thought leadership
Seven proposals for supporting the growth of scaleup businesses
Our plan to unlock the creativity, power and ingenuity of scaleup businesses for the good of the broad economy
A post exit perspective with Arcinova’s exec chairman, Professor Ian Shott CBE
BGF announced its exit of Arcinova in February. Following a period of growth, the business was acquired by Quotient Sciences, the drug development and…
Making Sense of Change: A new era of innovation in life sciences?
Some are focused on supporting the national fight against the virus, while others are exploring ways of continuing to provide support.
We’re ready. Are you?
Want to join some of the nation’s most ambitious and successful companies? We’re always looking for the next brilliant business to back.Tell us about your business